‘Rare Genomics : Genomics of Rare Diseases, Rare Cancers & Rare Drug Outcomes’
The 2018 Golden Helix Summer School was successfully organized on September 26-30, 2018 at Syros Island, Greece.
‘Rare Genomics : Genomics of Rare Diseases, Rare Cancers & Rare Drug Outcomes’
The 2018 Golden Helix Summer School was successfully organized on September 26-30, 2018 at Syros Island, Greece.
We are pleased to announce the 2018 Golden Helix Summer School that will be held in the island of Syros, Greece, the capital of the Cyclades islands in the Aegean archipelago. The 2018 Golden Helix Summer School will be organized in September 2018 and the theme of the Summer School will be "Rare Genomics: Genomics of Rare Diseases, Rare Cancers and rare Drug Outcomes" and will revolve around the application of the most important disciplines of Genomic Medicine, such as Genome discovery, informatics, Public Health, and drug design in Rare Diseases, Cancer and Pharmacogenomics.
We invite you to help promote the National Cancer Institute (NCI) Genomic Data Commons (GDC) to your internal and external audiences via social media, email, and the web. The GDC provides the cancer research community with a unified data system that promotes sharing of genomic and clinical data between researchers. You are welcome to use some or all of the following content or feel free to create your own based on the Genomic Data Commons website or NCI’s Center for Cancer Genomics’ website.
If you have questions about this digital-promotion toolkit, please email This email address is being protected from spambots. You need JavaScript enabled to view it..
The 2016 Golden Helix Summer School with the theme "Cancer Genomics and Individualized Therapy" was successfully organized at the Dolphin Bay Resort hotel in Syros island, Greece, 22-26 September 2016. The meeting was attended by 90 participants, guest speakers and company representatives from more than 20 countries worldwide, such as Greece and also the United States, United Kingdom, United Arab Emirates, Ecuador, Korea, China, Slovenia, Italy, Germany, the Netherlands, Ireland, etc.
The Genomic Medicine Alliance proudly announces the formation of the DRIFT Consortium with Regeneron Genetics Center (RGC). The DRIFT (Discovery Research Investigating Founder Population Traits) Consortium is an open call for research collaboration to understand the genetic architecture of founder populations throughout the world to impact health and disease.